Robert Hallowell, MD
Director, Interstitial Lung Disease (ILD) Program
Director, Pulmonary Ambulatory Practice
Assistant Professor of Medicine
Academic Interests
Anti-synthetase Syndrome, Connective Tissue Disease-Associated ILD, Myositis-associated ILD, Hypersensitivity Pneumonitis, Idiopathic Pulmonary Fibrosis (IPF).
Awards and Recognition
Harvard Pulmonary and Critical Care Fellowship Teacher of the Year
More information can be found on Dr. Hallowell's Harvard Catalyst Profile.
+Current Projects
Dr. Hallowell’s research focuses on factors that influence outcomes in patients with various types of interstitial lung disease (ILD), including pulmonary fibrosis. Through the creation of our large ILD database spanning the Harvard hospitals, I aim to better characterize the natural history of disease phenotypes in different ILD patient populations through their link to autoantibodies, with the ultimate goal being to optimize treatment algorithms. My work has afforded me the privilege to collaborate with colleagues across multiple disciplines, including but not limited to Radiology, Pathology, and Rheumatology. In parallel, I am an investigator on several clinical trials related to pulmonary fibrosis.